ARQT vs EIX
Arcutis Biotherapeutics Inc (ARQT) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Arcutis Biotherapeutics Inc (ARQT) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ARQT revenue for 2024-12-31 was $196.5M. Net income was -$140.0M. Revenue was up 229.7% from 2023-12-31 to 2024-12-31. ARQT currently screens at market cap $1.64B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ARQT currently screens at market cap $1.64B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ARQT and EIX stock pages for the full models.
Not investment advice.